+39 081.123.4567 segreteria@biologia.dip.unina.it

ImmuNAPOLI 2018: Microbiota role in cancer and in cancer therapy

ImmuNAPOLI 2018: Microbiota role in cancer and in cancer therapy

Di In Avvisi Il 26 luglio 2018

ImmuNapoli 2018 will host Dr. Giorgio Trinchieri,
NIH Distinguished Investigator and Director Center for Cancer Research
National Cancer Institute, NIH (Bethesda, MD, USA).

The topic of the Lectio Magistralis held by Dr. Trinchieri is:

“Microbiota role in cancer and cancer therapy”

Commensal microorganisms colonize barrier surfaces of all multicellular organisms, including those of humans. For more than 500 million years commensal microorganisms and their hosts have coevolved and adapted to each other. As a result, the commensal microbiota affects many immune and non-immune functions of their hosts, and de facto the two together comprise one metaorganism. The commensal microbiota communicates with the host via biologically active molecules. Recently, it has been reported that microbial imbalance may play a critical role in the development of multiple diseases, such as cancer, autoimmune conditions and increased susceptibility to infection. The commensal microbiota not only may affect the development, progression and immune evasion of cancer but it has also important effects on the response to cancer immune- and chemo-therapy. Myeloid cells are a major component of the tumor microenvironment where they play a dual role inducing anti-tumor immune responses but mostly promoting immune evasion, tumor progression and metastases formation. Myeloid cells respond to environmental factors including signals derived from commensal microbes that modulate their function and reactivity thus impacting the response to cancer therapy.

We would appreciate if you could forward this invitation to those who may be interested in at your institution.

We are looking forward to welcome you to ImmuNapoli 2018!

Kind regards,

The IBP Immunology Group